117 related articles for article (PubMed ID: 32909371)
1. Genetics of neuropsychiatric symptoms in patients with Alzheimer's disease: A 1-year follow-up study.
Huang MF; Lee WJ; Yeh YC; Liao YC; Wang SJ; Yang YH; Chen CS; Fuh JL
Psychiatry Clin Neurosci; 2020 Dec; 74(12):645-651. PubMed ID: 32909371
[TBL] [Abstract][Full Text] [Related]
2. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E epsilon4 allele increases risk for psychotic symptoms in Alzheimer's disease.
Zdanys KF; Kleiman TG; MacAvoy MG; Black BT; Rightmer TE; Grey M; Garman KS; Tampi RR; Gelernter J; van Dyck CH
Neuropsychopharmacology; 2007 Jan; 32(1):171-9. PubMed ID: 16841077
[TBL] [Abstract][Full Text] [Related]
4. Association Between Psychosis Phenotype and APOE Genotype on the Clinical Profiles of Alzheimer's Disease.
Qian W; Fischer CE; Schweizer TA; Munoz DG
Curr Alzheimer Res; 2018; 15(2):187-194. PubMed ID: 28847281
[TBL] [Abstract][Full Text] [Related]
5. Genetic association between APOE*4 and neuropsychiatric symptoms in patients with probable Alzheimer's disease is dependent on the psychosis phenotype.
Christie D; Shofer J; Millard SP; Li E; Demichele-Sweet MA; Weamer EA; Kamboh MI; Lopez OL; Sweet RA; Tsuang D
Behav Brain Funct; 2012 Dec; 8():62. PubMed ID: 23270420
[TBL] [Abstract][Full Text] [Related]
6. Association between apolipoprotein E epsilon4 allele and apathy in probable Alzheimer's disease.
Monastero R; Mariani E; Camarda C; Ingegni T; Averna MR; Senin U; Camarda R; Mecocci P
Acta Psychiatr Scand; 2006 Jan; 113(1):59-63. PubMed ID: 16390371
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of late-onset Alzheimer disease genetic susceptibility risks in a Canadian population.
Omoumi A; Fok A; Greenwood T; Sadovnick AD; Feldman HH; Hsiung GY
Neurobiol Aging; 2014 Apr; 35(4):936.e5-12. PubMed ID: 24176626
[TBL] [Abstract][Full Text] [Related]
8. Effects of SORL1 gene on Alzheimer's disease. Focus on gender, neuropsychiatric symptoms and pro-inflammatory cytokines.
Olgiati P; Politis A; Albani D; Rodilossi S; Polito L; Zisaki A; Piperi C; Liappas I; Stamouli E; Mailis A; Batelli S; Forloni G; Marsano A; Balestri M; Soldatos CR; De Ronchi D; Kalofoutis A; Serretti A
Curr Alzheimer Res; 2013 Feb; 10(2):154-64. PubMed ID: 23463934
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric symptoms predict change in quality of life of Alzheimer disease patients: a two-year follow-up study.
Tatsumi H; Nakaaki S; Torii K; Shinagawa Y; Watanabe N; Murata Y; Sato J; Mimura M; Furukawa TA
Psychiatry Clin Neurosci; 2009 Jun; 63(3):374-84. PubMed ID: 19566770
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychiatric symptoms and Apolipoprotein E: Associations with eventual Alzheimer's disease development.
Burke SL; Maramaldi P; Cadet T; Kukull W
Arch Gerontol Geriatr; 2016; 65():231-8. PubMed ID: 27111252
[TBL] [Abstract][Full Text] [Related]
11. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer's Disease?
Siokas V; Aslanidou P; Aloizou AM; Peristeri E; Stamati P; Liampas I; Arseniou S; Drakoulis N; Aschner M; Tsatsakis A; Mitsias PD; Bogdanos DP; Hadjigeorgiou GM; Dardiotis E
J Mol Neurosci; 2020 Jun; 70(6):851-860. PubMed ID: 32088842
[TBL] [Abstract][Full Text] [Related]
12. Interaction between variants in CLU and MS4A4E modulates Alzheimer's disease risk.
Ebbert MTW; Boehme KL; Wadsworth ME; Staley LA; ; ; Mukherjee S; Crane PK; Ridge PG; Kauwe JSK
Alzheimers Dement; 2016 Feb; 12(2):121-129. PubMed ID: 26449541
[TBL] [Abstract][Full Text] [Related]
13. Sex Differences in Neuropsychiatric Symptoms of Alzheimer's Disease: The Modifying Effect of Apolipoprotein E ε4 Status.
Xing Y; Tang Y; Jia J
Behav Neurol; 2015; 2015():275256. PubMed ID: 26538817
[TBL] [Abstract][Full Text] [Related]
14. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
[TBL] [Abstract][Full Text] [Related]
15. Butyrylcholinesterase K and apolipoprotein ε4 affect cortical thickness and neuropsychiatric symptoms in Alzheimer's disease.
Yoo HB; Lee HW; Shin S; Park SW; Choi JS; Jung HY; Cha J; Lee JM; Lee JY
Curr Alzheimer Res; 2014 Feb; 11(2):137-44. PubMed ID: 24479631
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric symptoms and mortality among patients with mild cognitive impairment and dementia due to Alzheimer's disease.
Huang MF; Lee WJ; Yeh YC; Lin YS; Lin HF; Wang SJ; Yang YH; Chen CS; Fuh JL
J Formos Med Assoc; 2022 Sep; 121(9):1705-1713. PubMed ID: 34933801
[TBL] [Abstract][Full Text] [Related]
17. The APOE polymorphism in Alzheimer's disease patients with neuropsychiatric symptoms and syndromes.
D'Onofrio G; Panza F; Seripa D; Sancarlo D; Paris F; Cascavilla L; Urbano M; Gravina C; Fontana A; Solfrizzi V; Pellegrini F; Pilotto A
Int J Geriatr Psychiatry; 2011 Oct; 26(10):1062-70. PubMed ID: 21905100
[TBL] [Abstract][Full Text] [Related]
18. Sorl1 as an Alzheimer's disease predisposition gene?
Webster JA; Myers AJ; Pearson JV; Craig DW; Hu-Lince D; Coon KD; Zismann VL; Beach T; Leung D; Bryden L; Halperin RF; Marlowe L; Kaleem M; Huentelman MJ; Joshipura K; Walker D; Heward CB; Ravid R; Rogers J; Papassotiropoulos A; Hardy J; Reiman EM; Stephan DA
Neurodegener Dis; 2008; 5(2):60-4. PubMed ID: 17975299
[TBL] [Abstract][Full Text] [Related]
19. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.
Naj AC; Jun G; Beecham GW; Wang LS; Vardarajan BN; Buros J; Gallins PJ; Buxbaum JD; Jarvik GP; Crane PK; Larson EB; Bird TD; Boeve BF; Graff-Radford NR; De Jager PL; Evans D; Schneider JA; Carrasquillo MM; Ertekin-Taner N; Younkin SG; Cruchaga C; Kauwe JS; Nowotny P; Kramer P; Hardy J; Huentelman MJ; Myers AJ; Barmada MM; Demirci FY; Baldwin CT; Green RC; Rogaeva E; St George-Hyslop P; Arnold SE; Barber R; Beach T; Bigio EH; Bowen JD; Boxer A; Burke JR; Cairns NJ; Carlson CS; Carney RM; Carroll SL; Chui HC; Clark DG; Corneveaux J; Cotman CW; Cummings JL; DeCarli C; DeKosky ST; Diaz-Arrastia R; Dick M; Dickson DW; Ellis WG; Faber KM; Fallon KB; Farlow MR; Ferris S; Frosch MP; Galasko DR; Ganguli M; Gearing M; Geschwind DH; Ghetti B; Gilbert JR; Gilman S; Giordani B; Glass JD; Growdon JH; Hamilton RL; Harrell LE; Head E; Honig LS; Hulette CM; Hyman BT; Jicha GA; Jin LW; Johnson N; Karlawish J; Karydas A; Kaye JA; Kim R; Koo EH; Kowall NW; Lah JJ; Levey AI; Lieberman AP; Lopez OL; Mack WJ; Marson DC; Martiniuk F; Mash DC; Masliah E; McCormick WC; McCurry SM; McDavid AN; McKee AC; Mesulam M; Miller BL; Miller CA; Miller JW; Parisi JE; Perl DP; Peskind E; Petersen RC; Poon WW; Quinn JF; Rajbhandary RA; Raskind M; Reisberg B; Ringman JM; Roberson ED; Rosenberg RN; Sano M; Schneider LS; Seeley W; Shelanski ML; Slifer MA; Smith CD; Sonnen JA; Spina S; Stern RA; Tanzi RE; Trojanowski JQ; Troncoso JC; Van Deerlin VM; Vinters HV; Vonsattel JP; Weintraub S; Welsh-Bohmer KA; Williamson J; Woltjer RL; Cantwell LB; Dombroski BA; Beekly D; Lunetta KL; Martin ER; Kamboh MI; Saykin AJ; Reiman EM; Bennett DA; Morris JC; Montine TJ; Goate AM; Blacker D; Tsuang DW; Hakonarson H; Kukull WA; Foroud TM; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD
Nat Genet; 2011 May; 43(5):436-41. PubMed ID: 21460841
[TBL] [Abstract][Full Text] [Related]
20. Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls.
Bellenguez C; Charbonnier C; Grenier-Boley B; Quenez O; Le Guennec K; Nicolas G; Chauhan G; Wallon D; Rousseau S; Richard AC; Boland A; Bourque G; Munter HM; Olaso R; Meyer V; Rollin-Sillaire A; Pasquier F; Letenneur L; Redon R; Dartigues JF; Tzourio C; Frebourg T; Lathrop M; Deleuze JF; Hannequin D; Genin E; Amouyel P; Debette S; Lambert JC; Campion D;
Neurobiol Aging; 2017 Nov; 59():220.e1-220.e9. PubMed ID: 28789839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
